Hunan Warrant Pharmaceutical (688799.SS) Earnings Analysis

Hunan Warrant Pharmaceutical (688799.SS) has no confirmed upcoming earnings date. Trailing P/E 27.34.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 688799.SS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 688799.SS. This page updates as the calendar is published.

688799.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-130.25 CNYn/an/an/a
2025-10-311.45 CNYn/an/an/a
2025-06-300.3192 CNYn/an/an/a
2025-04-210.44 CNYn/an/an/a
2025-02-260.063 CNYn/an/an/a

688799.SS valuation and analyst view

Trailing P/E27.34
Trailing EPS1.69 CNY
Price / book3.06
Dividend yield0.38%
Market cap6.33B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Hunan Warrant Pharmaceutical (688799.SS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 688799.SS. This page updates as the calendar is published.

Did 688799.SS beat earnings last quarter?

Consensus estimate data was not available for 688799.SS's 2026-02-13 report.

What is 688799.SS's current P/E ratio and EPS?

688799.SS trades at a trailing P/E of 27.34 on trailing EPS of 1.6901505554589922 CNY.

What do analysts rate 688799.SS?

688799.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.